Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 8/20 | 0.39 |
| ▸ | CA2 | P00918 | 8/20 | 0.39 |
| ▸ | CA9 | Q16790 | 7/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.39 |
| ▸ | CA12 | O43570 | 3/20 | 0.39 |
| ▸ | CA7 | P43166 | 3/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.39 |
| ▸ | CA3 | P07451 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | CA6 | P23280 | 2/20 | 0.39 |
| ▸ | CA5A | P35218 | 2/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1723840 | 1.00 | CES2 (0.42) | CES2EPHX2CA1CA2CA9 | |
| SCHEMBL1747658 | 1.00 | CES2 (0.42) | CES2EPHX2CA1CA2CA9 | |
| SCHEMBL1723124 | 0.98 | CES2 (0.39) | CES2EPHX2CA1CA2CA9 | |
| SCHEMBL1723807 | 0.91 | — | — | |
| SCHEMBL4304767 | 0.88 | EPHX2 (0.46) | CES2EPHX2CA1CA2CA9 | |
| SCHEMBL9129611 | 0.88 | EPHX2 (0.46) | CES2EPHX2CA1CA2CA9 | |
| SCHEMBL28383874 | 0.88 | EPHX2 (0.46) | CES2EPHX2CA1CA2CA9 | |
| SCHEMBL4299797 | 0.88 | EPHX2 (0.46) | CES2EPHX2CA1CA2CA9 | |
| SCHEMBL28888136 | 0.88 | EPHX2 (0.46) | CES2EPHX2CA1CA2CA9 | |
| SCHEMBL778726 | 0.88 | EPHX2 (0.46) | CES2EPHX2CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1902004-B1 | ONIUM-ALKYLSULFONATE PRODUCTION METHOD | MERCK PATENT GMBH (DE) | 2012-01-18 | — | — | EP | disclosed |
| US-7999111-B2 | Reacting an onium halide or carboxylate with a symmetrically substituted dialkyl sulfite or with an asymmetrically substituted dialkyl sulfite; 1-hexyl-3-methylimidazolium chloride and dimethyl sulfite; 1-Hexyl-3-methylimidazolium methanesulfonate | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-08-16 | — | — | US | disclosed |
| US-20080227987-A1 | Process for the Preparation of Onium Alkylsulfites | MERCK PATENT GMBH (DE) | 2008-09-18 | — | — | US | disclosed |
| US-20080221334-A1 | Process for the Preparation of Onium Alkylsulfonates | MERCK PATENT GESELLSCHAFT (DE) | 2008-09-11 | — | — | US | disclosed |
| EP-1902004-A2 | ONIUM-ALKYLSULFONATE PRODUCTION METHOD | Merck Patent GmbH (DE) | 2008-03-26 | — | — | EP | disclosed |
| EP-1902035-A1 | METHOD FOR THE PRODUCTION OF ONIUM ALKYL SULFITES | Merck Patent GmbH (DE) | 2008-03-26 | — | — | EP | disclosed |
| WO-2007006389-A1 | MIXTURE OF ONIUM ALKYL SULFONATES AND ONIUM ALKYL SULFITES | MERCK PATENT GMBH (DE) | 2007-01-18 | — | — | WO | disclosed |
| WO-2007006388-A1 | METHOD FOR THE PRODUCTION OF ONIUM ALKYL SULFITES | MERCK PATENT GMBH (DE) | 2007-01-18 | — | — | WO | disclosed |
| WO-2007006387-A2 | ONIUM-ALKYLSULFONATE PRODUCTION METHOD | MERCK PATENT GMBH (DE) | 2007-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221334-A1 | Process for the Preparation of Onium Alkylsulfonates | STS, ARSA, AGPS | CES2 810/4885EPHX2 2248/4885CA1 2392/4885 |
| US-20080227987-A1 | Process for the Preparation of Onium Alkylsulfites | STS, ARSA, ADSL | CES2 766/4885EPHX2 1737/4885CA1 2243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.